Methadone Therapy - One Dose Does Not Fit All
Study supports a flexible approach to methadone dosing
Methadone has been used for more than 30 years as a treatment for heroin addicts. Doctors have all along struggled to find the best doses to help patients overcome their heroin cravings without getting them used to higher levels of methadone (itself an dependence-forming substance) than necessary. A new study by Jodie Trafton and colleagues (from the VA Palo Alto Health Care System) provides strong support for the notion that there is no one dose that fits all.
Current guidelines recommend methadone doses of at least 60 milligrams (per kilogram bodyweight). However, doctors in methadone clinics report a wide range of doses that are effective, and quite a few clinics treat patients with starting doses that are lower or higher than the recommended amount. Trafton and colleagues studied 222 heroin addicted volunteers who started methadone treatment at 8 different clinics and followed them for up to a year. They examined the range of methadone doses which helped patients achieve heroin abstinence and the factors that influenced whether a particular patient needed a higher or a lower dose.
The range of effective methadone doses (among the 168 patients who achieved abstinence) was very wide, from 1.5 mg to 191.2 mg. 38% of the patients achieved abstinence on less than 60 mg, and 16% of the abstinent patients received a dose of over 100 mg. On the other hand, almost half of the patients who did not achieve heroin abstinence received the recommended dose of 60 mg or more. Overall, patients at clinics that generally adhered to the treatment guidelines (and treated most patients at 60mg or higher) achieved longer periods of abstinence. Among patients who achieved abstinence, higher methadone doses were correlated with post-traumatic stress disorder, depression, a higher number of previous detoxifications from heroin, and some other factors.
These results confirm that effective methadone doses vary very widely. Even high doses that work for one patient do not necessarily work for another, and a substantial percentage of patients achieve abstinence on less than the recommended dose. The study also identifies some factors, such as post-traumatic stress disorder and depression, that seem to influence whether a patient is more likely to need a higher dose. The authors conclude that doctors should work with each patient to find the lowest effective dose for that individual. Because patients in clinics that adhere to the guidelines do better on average, the recommended dose should serve as a starting point that is then adjusted upward or downward.
Andrew Hyde | alfa
The most recent press releases about innovation >>>
Die letzten 5 Focus-News des innovations-reports im Überblick:
In recent years, lasers with ultrashort pulses (USP) down to the femtosecond range have become established on an industrial scale. They could advance some applications with the much-lauded “cold ablation” – if that meant they would then achieve more throughput. A new generation of process engineering that will address this issue in particular will be discussed at the “4th UKP Workshop – Ultrafast Laser Technology” in April 2017.
Even back in the 1990s, scientists were comparing materials processing with nanosecond, picosecond and femtosesecond pulses. The result was surprising:...
Mapping the interaction of a single atom with a single photon may inform design of quantum devices
Have you ever wondered how you see the world? Vision is about photons of light, which are packets of energy, interacting with the atoms or molecules in what...
A multi-institutional research collaboration has created a novel approach for fabricating three-dimensional micro-optics through the shape-defined formation of porous silicon (PSi), with broad impacts in integrated optoelectronics, imaging, and photovoltaics.
Working with colleagues at Stanford and The Dow Chemical Company, researchers at the University of Illinois at Urbana-Champaign fabricated 3-D birefringent...
In experiments with magnetic atoms conducted at extremely low temperatures, scientists have demonstrated a unique phase of matter: The atoms form a new type of quantum liquid or quantum droplet state. These so called quantum droplets may preserve their form in absence of external confinement because of quantum effects. The joint team of experimental physicists from Innsbruck and theoretical physicists from Hannover report on their findings in the journal Physical Review X.
“Our Quantum droplets are in the gas phase but they still drop like a rock,” explains experimental physicist Francesca Ferlaino when talking about the...
The Max Planck Institute for Physics (MPP) is opening up a new research field. A workshop from November 21 - 22, 2016 will mark the start of activities for an innovative axion experiment. Axions are still only purely hypothetical particles. Their detection could solve two fundamental problems in particle physics: What dark matter consists of and why it has not yet been possible to directly observe a CP violation for the strong interaction.
The “MADMAX” project is the MPP’s commitment to axion research. Axions are so far only a theoretical prediction and are difficult to detect: on the one hand,...